1 Min Read
Oct 5 (Reuters) - Fate Therapeutics Inc :
* Fate Therapeutics announces issuance of U.S. patent protecting enhanced hematopoietic stem cell compositions Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.